2) Endocrinology and Diabetology Service – Verdelli, Chiara

Publications

Verdelli C, Avagliano L, Guarnieri V et al. Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors. Lab Invest 2017 doi:0.1038/labinvest.2017.88.

Verdelli C, Corbetta S. Epigenetic Alterations in Parathyroid Cancers. Int J Mol Sci. 2017 1;18(2).

Vaira V, Verdelli C, Forno I, Corbetta S. MicroRNAs in parathyroid physiopathology. Mol Cell Endocrinol. 2017 15;456:9-15.

Mingione A, Verdelli C, Ferrero S, et al Filamin A is reduced and contributes to the calcium-sensing receptor sensitivity in human parathyroid tumors. J Mol Endocrinol. 2017 Feb;58(2):91-103.

Verdelli C, Corbetta S. MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects. Eur J Endocrinol. 2017 Jan;176(1): R39-R52.

Mingione A, Verdelli C, Terranegra A, Soldati L et al. Molecular and clinical Aspects of target therapy with the calcimimetic cinacalcet in the treatment of parathyroid tumors. Curr Cancer Drug Targets. 2015;15(7):563-74.

Verdelli C, Avagliano L, Creo P, Guarnieri V, et al. Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia. Endocr Relat Cancer. 2015 Feb;22(1):87-98.

Bizzozero L, Cazzato D, Cervia D, Assi E et al. Acid sphingomyelinase determines melanoma development, progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway. Cell Death Differentiation. 2014; 21(4):507-20.

Valaperta R, Sansone V, Lombardi F, Verdelli C, et al. Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments. Biomed Res Int. 2013;2013:958510.

Vaira V, Elli F, Forno I, Guarnieri V, et al. The microRNA cluster C19MC is deregulated in parathyroid tumours. J. Molecular Endocrinology. 2012;49(2):115-24.